With 5-year survival rates remaining constant at 6% and rising incidences associated with
an epidemic in obesity and metabolic syndrome, pancreatic ductal adenocarcinoma (PDAC) …

Many nanocarrier cancer therapeutics currently under development, as well as those used
in the clinical setting, rely upon the enhanced permeability and retention (EPR) effect to …

Ovarian cancer (OC) is considered fifth-deadliest cancer globally responsible for high
mortality in women. As the conventional therapeutic and diagnostic approaches are …

Nanomedicines have significant potential for cancer treatment. Although the majority of
nanomedicines currently tested in clinical trials utilize simple, biocompatible liposome …

Although small interfering RNA (siRNA) holds great therapeutic promise, its delivery to the
disease site remains a paramount obstacle. In this study, we tested whether brain …

Mesoporous silica nanoparticle‐supported lipid bilayers, termed 'protocells,'represent a
potentially transformative class of therapeutic and theranostic delivery vehicle. The field of …

Gold nanoparticles (AuNPs) show potential for transfecting target cells with small interfering
RNA (siRNA), but the influence of key design parameters such as the size and shape of the …

Wound dressing is an important tool for wound management. Designing wound dressings
by combining various novel materials and drugs to optimize the peri-wound environment …

In chemotherapy, it is a great challenge to recruit endogenous stimuli instead of external
intervention for targeted delivery and controlled release; microRNAs are the most promising …

Colorectal cancer (CRC) is the third cause of cancer death in the world that arises from the
glandular and epithelial cells of the large intestine, during a series of genetic or epigenetic …